Science
Early Data Indicates an A.I.-Generated Drug Could Slow Aging
Key Points
Rentosertib, Insilico Medicine’s small-molecule drug candidate developed and designed using generative A.I. for treating chronic lung disease, at the company’s research and development facility in Shanghai.
Rentosertib, Insilico Medicine’s small-molecule drug candidate developed and designed using generative A.I. for treating chronic lung disease, at the company’s research and development facility in Shanghai.
[Image text:] POCAS
Rentosertib
ISM001-055
TNIK
IPF